JAN 19, 2017 8:00 AM PST

Webinar: Detecting meaningful mutations from liquid biopsies by Anchored Multiplex PCR

Sponsored by: ArcherDX, ArcherDX
Speakers
  • Chief Scientific Officer and General Manager at ArcherDX
    Biography
      Originally from Baltimore, MD, Josh Stahl studied biochemistry and molecular biology at West Virginia University. He went to graduate school at the University of Colorado, Boulder, working on protein-protein interactions in morphine analgesia.

      Josh joined ArcherDX in 2013, and has overseen biochemistry, molecular biology, and software development since that time. Now general manager and chief scientific office, Josh continues to lead Archer R&D, product development and operations teams in developing new applications and Archer technology
    • Product Manager at ArcherDX
      Biography
        Jonathan Doose completed his post-graduate studies at the University of California, Riverside where he investigated the molecular mechanism of CNS immune privilege in microglia and potential new therapeutic targets in neurodegenerative autoimmune diseases. He joined ArcherDX in early 2016 and manages FusionPlex and VariantPlex assay development. Jonathan was essential in bringing the Archer Reveal ctDNA assay to market and continues to harness his scientific expertise to develop new applications for Archer technology.

      Abstract:

      DATE: January 19th, 2017
      TIME: 8:00AM PT, 11:00AM ET


      Liquid biopsies have the potential to be a less invasive method than traditional biopsies to detect advanced solid tumor mutational status. Cell free DNA (cfDNA) can be profiled from liquid biopsy samples, although the abundance is generally low, ranging from less than 1ng to 30ng cfDNA per mL blood in healthy individuals. Furthermore, only a small fraction of cfDNA originates from tumor cells as circulating tumor DNA (ctDNA), except in more advanced disease states. This ctDNA is typically highly fragmented (100-300bp), and thus NGS-based methods to detect oncogenic driver mutations from liquid biopsies must be sensitive enough to detect low-frequency mutations (allele fractions less than 2%) from low inputs (10-100ng) of highly fragmented material.
       
      Anchored Multiplex PCR (AMP™) is proprietary target enrichment chemistry for NGS that is uniquely suited for highly fragmented material such as FFPE-derived nucleic acids and liquid biopsy-derived ctDNA. In this webinar, Josh Stahl, Chief Scientific Officer and General Manager at ArcherDX, will describe AMP-based ctDNA library preparation method, highlighting the use and advantages of molecular barcoded adapters used to unambiguously remove PCR duplicates, correct for PCR or sequencer-derived sequence errors, and flag run-to-run contamination. Josh will further talk about how the Archer® Reveal ctDNA™ 28 kit combines robust variant detection and quantitative analysis with single-day library prep for powerful, accurate and fast mutation analysis from liquid biopsies.
       
      Learning objective 1: Understand both the value of mutation analysis from ctDNA in liquid biopsies and the challenges of analyzing ctDNA by next-generation sequencing.
       
      Learning objective 2: Learn how the Archer Reveal ctDNA 28 kit uses Anchored Multiplex PCR target enrichment chemistry to detect and characterize ctDNA.

       


      Show Resources
      You May Also Like
      AUG 27, 2019 9:00 AM PDT
      C.E. CREDITS
      AUG 27, 2019 9:00 AM PDT
      DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
      OCT 02, 2019 11:00 AM PDT
      OCT 02, 2019 11:00 AM PDT
      DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
      NOV 18, 2019 7:00 AM PST
      C.E. CREDITS
      NOV 18, 2019 7:00 AM PST
      DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
      JAN 23, 2020 9:00 AM PST
      C.E. CREDITS
      JAN 23, 2020 9:00 AM PST
      DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
      FEB 25, 2020 9:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      FEB 25, 2020 9:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
      MAR 03, 2020 9:00 AM JST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      MAR 03, 2020 9:00 AM JST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
      Loading Comments...
      Show Resources